Proteomic Startup CS-Keys Attracts VC Seed Funding
Indianapolis-based CS-Keys received an investment from Triathlon Medical Ventures, the second investment CS has received since its creation in 2005, the company said this week.
The amount of the investment was not disclosed.
CS-Keys will use the funds to continue research and development of cancer-specific biomarkers and for marketing and regulatory strategies of the company.
Earlier this year, CS received a $285,000 investment from the Indiana Seed Fund.